Expand All Collapse All

Statistics at a Glance

At a Glance

Estimated New Cases in 2024 2,001,140

% of All New Cancer Cases 100.0%

Estimated Deaths in 2024 611,720

% of All Cancer Deaths 100.0%

5-Year
Relative Survival

69.2% 2014–2020
Year Rate of New Cases — SEER 8 Rate of New Cases — SEER 12 Death Rate — U.S. 5-Year Relative Survival — SEER 8
Observed Modeled Trend Observed Modeled Trend Observed Modeled Trend Observed Modeled Trend
1975 400.32 400.86 - - 199.14 201.20 49.85% 49.94%
1976 405.56 403.05 - - 202.30 202.12 50.35% 50.25%
1977 404.99 405.24 - - 203.02 203.05 50.32% 50.57%
1978 404.07 407.45 - - 204.42 203.98 50.48% 50.89%
1979 409.65 409.66 - - 204.53 204.91 49.85% 51.20%
1980 412.21 411.89 - - 206.96 205.85 50.41% 51.52%
1981 417.06 414.13 - - 206.40 206.79 51.09% 51.83%
1982 414.75 416.39 - - 208.32 207.74 51.06% 52.14%
1983 422.05 423.63 - - 209.21 208.69 52.07% 52.45%
1984 432.12 430.99 - - 210.91 209.64 52.20% 52.76%
1985 441.94 438.48 - - 211.35 210.60 53.74% 53.85%
1986 444.62 446.10 - - 211.79 211.57 54.55% 54.92%
1987 461.16 453.85 - - 211.91 212.54 55.68% 55.97%
1988 457.79 461.74 - - 212.62 213.51 56.44% 57.02%
1989 460.28 469.76 - - 214.30 214.49 56.65% 58.04%
1990 474.01 477.93 - - 214.95 215.47 58.67% 59.06%
1991 492.54 486.24 - - 215.06 214.78 60.78% 60.05%
1992 500.02 494.69 495.02 493.31 213.46 214.10 62.34% 61.04%
1993 481.44 485.12 477.91 481.27 213.45 213.42 61.85% 61.65%
1994 473.13 475.73 467.05 469.52 211.74 211.18 61.71% 62.25%
1995 467.46 466.53 464.02 469.29 209.89 208.97 62.17% 62.85%
1996 470.94 470.15 466.46 469.05 207.00 206.78 63.37% 63.45%
1997 476.62 473.79 470.76 468.81 203.55 204.61 64.15% 64.03%
1998 476.96 477.46 471.29 468.58 200.82 202.46 64.74% 64.61%
1999 480.86 481.16 473.51 468.34 200.72 200.34 65.89% 65.19%
2000 476.18 480.86 466.75 468.11 198.79 198.23 66.65% 65.75%
2001 486.77 480.56 476.95 467.87 196.29 196.15 67.57% 66.31%
2002 484.61 480.26 472.30 467.63 194.36 193.27 67.94% 66.87%
2003 474.57 479.96 463.29 467.40 190.89 190.43 67.39% 67.41%
2004 477.63 479.67 466.36 467.16 186.84 187.63 68.24% 67.95%
2005 474.99 479.37 463.14 466.93 185.23 184.87 68.74% 68.48%
2006 479.62 479.07 464.47 466.69 182.03 182.15 69.56% 69.01%
2007 484.10 478.77 470.90 466.46 179.26 179.48 70.02% 69.30%
2008 478.85 478.48 465.31 466.22 176.32 176.84 70.01% 69.60%
2009 478.14 478.18 464.37 465.99 173.40 174.24 70.39% 69.89%
2010 468.51 470.03 455.08 456.70 171.81 171.68 70.25% 70.17%
2011 462.57 462.02 447.65 447.59 169.06 169.15 70.38% 70.46%
2012 452.37 454.14 437.02 438.66 166.90 166.67 69.74% 70.74%
2013 446.87 446.40 431.25 429.91 164.00 164.22 70.31% 71.03%
2014 446.27 446.58 428.96 429.51 162.33 161.80 70.55% 71.30%
2015 448.04 446.77 430.16 429.12 159.98 159.42 71.46% 71.58%
2016 448.93 446.96 430.76 428.72 157.28 156.69 71.75% 71.86%
2017 448.48 447.14 428.97 428.32 154.12 154.01 - 72.13%
2018 442.83 447.33 422.74 427.93 150.82 151.37 - 72.40%
2019 447.59 447.52 428.65 427.53 147.76 148.78 - 72.67%
2020 404.41 447.70 387.53 427.14 145.62 146.23 - 72.94%
2021 448.95 447.89 427.82 426.74 144.16 143.73 - 73.20%
2022 - - - - 142.00 141.27 - 73.46%

New cases come from SEER 12. Deaths come from U.S. Mortality.
All Races, Both Sexes. Rates are Age-Adjusted.
Modeled trend lines were calculated from the underlying rates using the Joinpoint Trend Analysis Software.
The 2020 incidence rate is displayed but not used in the fit of the trend line(s). Impact of COVID on SEER Cancer Incidence 2020 data

New cases are also referred to as incident cases in other publications. Rates of new cases are also referred to as incidence rates.

Rate of New Cases and Deaths per 100,000: The rate of new cases of cancer of any site was 440.5 per 100,000 men and women per year. The death rate was 146.0 per 100,000 men and women per year. These rates are age-adjusted and based on 2017–2021 cases and 2018–2022 deaths.

Lifetime Risk of Developing Cancer: Approximately 39.3 percent of men and women will be diagnosed with cancer of any site at some point during their lifetime, based on 2018–2021 data, excluding 2020 due to COVID.

Prevalence of This Cancer: In 2021, there were an estimated 17,435,314 people living with cancer of any site in the United States.

Did You Know? Video Series

Survival Statistics

How Many People Survive 5 Years Or More after Being Diagnosed with Cancer of Any Site?

Relative survival is an estimate of the percentage of patients who would be expected to survive the effects of their cancer. It excludes the risk of dying from other causes. Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. No two patients are entirely alike, and treatment and responses to treatment can vary greatly.

69.2%

5-Year
Relative Survival

69.2%

Based on data from SEER 22 (Excluding IL/MA) 2014–2020. Gray figures represent those who have died from cancer of any site. Green figures represent those who have survived 5 years or more.

Additional Information

New Cases and Deaths

How Common Is This Cancer?

Common Types of Cancer Estimated New
Cases 2024		 Estimated
Deaths 2024
1. Breast Cancer (Female) 310,720 42,250
2. Prostate Cancer 299,010 35,250
3. Lung and Bronchus Cancer 234,580 125,070
4. Colorectal Cancer 152,810 53,010
5. Melanoma of the Skin 100,640 8,290
6. Bladder Cancer 83,190 16,840
7. Kidney and Renal Pelvis Cancer 81,610 14,390
8. Non-Hodgkin Lymphoma 80,620 20,140
9. Uterine Cancer 67,880 13,250
10. Pancreatic Cancer 66,440 51,750
- - -
Cancer of Any Site 2,001,140 611,720

In 2024, it is estimated that there will be 2,001,140 new cases of cancer of any site and an estimated 611,720 people will die of this disease.

Who Gets This Cancer?

Among racial/ethnic groups, there are more new cases among non-Hispanic Black men and non-Hispanic White women and fewer new cases among non-Hispanic Asian/Pacific Islanders of both sexes. The rate of new cases of cancer of any site was 440.5 per 100,000 men and women per year based on 2017–2021 cases, age-adjusted.

Rate of New Cases per 100,000 Persons by Race/Ethnicity & Sex: Cancer of Any Site
Males
All Races 478.7
Hispanic 367.0
Non-Hispanic American Indian/Alaska Native 442.2
Non-Hispanic Asian/Pacific Islander 299.8
Non-Hispanic Black 526.5
Non-Hispanic White 510.7
Females
All Races 416.7
Hispanic 347.8
Non-Hispanic American Indian/Alaska Native 421.1
Non-Hispanic Asian/Pacific Islander 313.2
Non-Hispanic Black 403.1
Non-Hispanic White 447.0

SEER 22 2017–2021, Age-Adjusted

Percent of New Cases by Age Group: Cancer of Any Site
Age Range Percent of New Cases
<20 1.0%
20–34 2.7%
35–44 4.8%
45–54 11.0%
55–64 23.8%
65–74 30.2%
75–84 19.0%
>84 7.6%

Cancer of any site is most frequently diagnosed among people aged 65–74.

Median Age
At Diagnosis

67

SEER 22 2017–2021, All Races, Both Sexes

Who Dies From This Cancer?

Death rates for cancer are higher among the middle-aged and elderly populations. The death rate was 146.0 per 100,000 men and women per year based on 2018–2022 deaths, age-adjusted.

Death Rate per 100,000 Persons by Race/Ethnicity & Sex: Cancer of Any Site
Males
All Races 173.2
Hispanic 126.8
Non-Hispanic American Indian/Alaska Native 185.8
Non-Hispanic Asian/Pacific Islander 107.5
Non-Hispanic Black 208.3
Non-Hispanic White 179.0
Females
All Races 126.4
Hispanic 93.2
Non-Hispanic American Indian/Alaska Native 140.9
Non-Hispanic Asian/Pacific Islander 82.6
Non-Hispanic Black 144.7
Non-Hispanic White 131.0

U.S. 2018–2022, Age-Adjusted

Percent of Deaths by Age Group: Cancer of Any Site
Age Range Percent of Deaths
<20 0.3%
20–34 0.7%
35–44 1.8%
45–54 5.8%
55–64 18.2%
65–74 29.0%
75–84 27.2%
>84 17.0%

The percent of cancer of any site deaths is highest among people aged 65–74.

Median Age
At Death

73

U.S. 2018–2022, All Races, Both Sexes

Trends in Rates

Changes Over Time

Keeping track of new cases, deaths, and survival over time (trends) can help scientists understand whether progress is being made and where additional research is needed to address challenges, such as improving screening or finding better treatments.

Using statistical models for analysis, age-adjusted rates for new cancer of any site cases have been stable over 2012–2021. Age-adjusted death rates have been falling on average 1.7% each year over 2013–2022. 5-year relative survival trends are shown below.

New Cases, Deaths and 5-Year Relative Survival

Interactive Statistics with SEER*Explorer

With SEER*Explorer, you can...
  • Create custom graphs and tables
  • Download data and images
  • Share links to results

SEER*Explorer is an interactive website that provides easy access to a wide range of SEER cancer statistics. It provides detailed statistics for a cancer site by sex, race, calendar year, age, and for a selected number of cancer sites, by stage and histology.

Explore Additional Cancer of Any Site Statistics

More About This Cancer

More Information

Here are some resources for learning more about cancer.

References

All statistics in this report are based on statistics from SEER and the Centers for Disease Control and Prevention's National Center for Health Statistics. Most can be found within SEER*Explorer.

Suggested Citation

All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

SEER Cancer Stat Facts: Cancer of Any Site. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/all.html

These stat facts focus on population statistics that are based on the U.S. population. Because these statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. To see tailored statistics, browse SEER*Explorer. To see statistics for a specific state, go to the State Cancer Profiles.

The statistics presented in these stat facts are based on the most recent data available, most of which can be found in SEER*Explorer. In some cases, different year spans may be used.

Estimates of new cases and deaths for 2024 are projections made by the American Cancer Society (ACS), based on earlier reported data.

Cancer is a complex topic. There is a wide range of information available. These stat facts do not address causes, symptoms, diagnosis, treatment, follow-up care, or decision making, although links are provided to information in many of these areas.